
Novavax (NVAX) Stock Surges YTD as COVID Vaccine Advances Well
Published on September 13, 2021
Upon approval and successful commercialization, Novavax's (NVAX) COVID-19 vaccine should reap huge revenues. The company's other pipeline candidates a...

Upon approval and successful commercialization, Novavax's (NVAX) COVID-19 vaccine should reap huge revenues. The company's other pipeline candidates a...